MICARDIS 40MG TAB 40 MG
TELMISARTAN : 40 MG · DIN 02240769 · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Health Canada status: MARKETED
What is MICARDIS 40MG TAB?
MICARDIS 40MG TAB 40 MG contains TELMISARTAN : 40 MG. It is listed in the Health Canada Drug Product Database under DIN 02240769, held by BOEHRINGER INGELHEIM (CANADA) LTD LTEE, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 01-Sep-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is MICARDIS 40MG TAB used for?
MICARDIS is indicated for the treatment of mild to moderate essential hypertension in adults. MICARDIS is also indicated to reduce the risk of non-fatal stroke or non-fatal myocardial infarction in adults 55 years or older at high risk of developing major cardiovascular events who cannot tolerate an angiotensin converting enzyme inhibitor (ACEI).
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02240769 |
|---|---|
| Brand name | MICARDIS 40MG TAB |
| Generic / active ingredient | TELMISARTAN : 40 MG |
| Manufacturer | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
| Strength | 40 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C09CA07 TELMISARTAN |
| AHFS class | 24:32.08 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 01-Sep-1999 |
| Original market date | 1999-09-01 00:00:00 |
How is it stored and handled?
null
How is it supplied?
28 tablets
Is TELMISARTAN in shortage in Canada?
A Canadian shortage report is on file for this molecule: Resolved — reported by SIVEM PHARMACEUTICALS ULC, last seen 13 May 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code C09CA07 TELMISARTAN. 26 of 52 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACH-TELMISARTAN | 40 MG | TABLET | ACCORD HEALTHCARE INC | MARKETED | DIN 02407485 |
| ACH-TELMISARTAN | 80 MG | TABLET | ACCORD HEALTHCARE INC | MARKETED | DIN 02407493 |
| AG-TELMISARTAN | 40 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02484536 |
| AG-TELMISARTAN | 80 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02484544 |
| AURO-TELMISARTAN | 40 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02453568 |
| AURO-TELMISARTAN | 80 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02453576 |
| JAMP TELMISARTAN | 40 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02386755 |
| JAMP TELMISARTAN | 80 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02386763 |
| MICARDIS 80MG TAB | 80 MG | TABLET | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | MARKETED | DIN 02240770 |
| MINT-TELMISARTAN | 40 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02486369 |
Who else supplies TELMISARTAN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TELMISARTAN appears in 482 registered pack listings across 14 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.